Correlation Between Bristol Myers and TC BioPharm
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and TC BioPharm plc, you can compare the effects of market volatilities on Bristol Myers and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and TC BioPharm.
Diversification Opportunities for Bristol Myers and TC BioPharm
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bristol and TCBPW is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and TC BioPharm plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm plc and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm plc has no effect on the direction of Bristol Myers i.e., Bristol Myers and TC BioPharm go up and down completely randomly.
Pair Corralation between Bristol Myers and TC BioPharm
Considering the 90-day investment horizon Bristol Myers is expected to generate 8.57 times less return on investment than TC BioPharm. But when comparing it to its historical volatility, Bristol Myers Squibb is 13.09 times less risky than TC BioPharm. It trades about 0.14 of its potential returns per unit of risk. TC BioPharm plc is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 2.90 in TC BioPharm plc on September 2, 2024 and sell it today you would lose (1.03) from holding TC BioPharm plc or give up 35.52% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Bristol Myers Squibb vs. TC BioPharm plc
Performance |
Timeline |
Bristol Myers Squibb |
TC BioPharm plc |
Bristol Myers and TC BioPharm Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bristol Myers and TC BioPharm
The main advantage of trading using opposite Bristol Myers and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
TC BioPharm vs. Protagenic Therapeutics | TC BioPharm vs. bioAffinity Technologies Warrant | TC BioPharm vs. American Rebel Holdings | TC BioPharm vs. Alvotech Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |